SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending sharply after achieving its first-ever quarterly profit with strong beats on earnings and revenue, alongside robust Q1 delivery guidance; the community is buzzing with bullish sentiment, viewing this as a significant turning point and comparing its potential to early Tesla, even as some express frustration over perceived market manipulation at key resistance levels.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to its approved $30M acceleration program for the Tanbreez HREE project and an analyst upgrade, which is fueling community discussion about its short squeeze potential. Investors are anticipating a favorable Bankable Feasibility Study update, focusing on the critical minerals sector's strategic importance, Greenland's heavy rare earths, and the project's 100% allocated initial production for Western supply chains.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is seeing extreme volatility as crude oil prices first surged on escalating Middle East tensions and potential Strait of Hormuz disruptions, then sharply reversed following Donald Trump's comments suggesting the Iran conflict is "very complete" and supply concerns are easing. The community is actively debating whether this represents a "rug pull" and a market top, or if it's a temporary dip before another rebound amid lingering geopolitical risks.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending following a substantial Q4 2025 earnings beat, propelled by accelerating MIPLYFFA sales that highlight its transition to a profitable commercial-stage company. The community is buzzing about this fundamental shift, anticipating analyst upgrades, further momentum from pending EU approval, and a potential short squeeze.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending with intense debate surrounding its earnings report, as the community weighs the potential for significant cloud revenue growth from its aggressive AI infrastructure buildout against concerns over rising debt and capital expenditures, further fueled by recent headlines regarding its data center expansion.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the FDA lifted the Complete Response Letter for its Duchenne Muscular Dystrophy therapy, Deramiocel, setting a PDUFA date of August 22, 2026. The community is highly optimistic for an expedited approval and a significant short squeeze, fueled by the departure of a key FDA official perceived as an obstacle to the drug's advancement.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech Inc. is gaining significant attention following its presentation at a virtual investor conference, which, combined with its tight share float and innovative fire-retardant wood technology, is generating bullish momentum and sparking community discussion about a potential technical breakout.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

Kohl's is trending following its Q4 earnings report, which, despite softer sales and cautious forward guidance, showcased an EPS beat and a strengthened balance sheet through cost discipline and debt reduction. The community is actively debating the company's underlying value and potential for a short squeeze amidst persistent selling pressure, weighing improved profitability against ongoing revenue challenges in the retail sector.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending due to recent analyst upgrades citing a compelling valuation, especially after the Talkspace acquisition, which has reignited community discussions about the company's deeply undervalued status as a global leader in virtual care with strong free cash flow and a clearer path to debt resolution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$OSTX The way this is behaving, I would not be surprised if we approached the $2 range this afternoon.

peter het

Sam I am

JTstockwatch

edward

JustC

Charles

Alexander Voitsekhovski

Ronald Beaver

Corey Workman

StockTwits for iOS

OS Therapies Inc

 The way this is behaving, I would not be surprised if we approached the $2 range this afternoon.

Nuburu Inc - Ordinary Shares - Class A

Applied Digital Corporation

Rezolve AI Limited

@TeaBaggerVance your thoughts where this goes in the next few months?

 your thoughts where this goes in the next few months?

Beasley Broadcast Group Inc - Ordinary Shares - Class A

Wheeler Real Estate Investment Trust Inc

Boxlight Corp

Envirotech Vehicles Inc

Venus Concept Inc

cbdMD Inc

C3is Ord Shs

Gaxos.AI Inc

@ZCOCSTOCK By the end of April I could see this around $4 and by July $7+. IF we get the right momentum it’s possible it goes much higher. These are my conservative predictions. How do you see it playing out?

 By the end of April I could see this around $4 and by July $7+. IF we get the right momentum it’s possible it goes much higher. These are my conservative predictions. How do you see it playing out?

@TeaBaggerVance staying optimistic and ready to go to $17-$20. That said, it is going to take some great catalysts, which are there, and help from other entities in the bio world. I have been here for a while so holding a little longer is not an issue.

 staying optimistic and ready to go to $17-$20. That said, it is going to take some great catalysts, which are there, and help from other entities in the bio world. I have been here for a while so holding a little longer is not an issue.